Search
phospholipase A2 group 7; platelet-activating factor acetylhydrolase; PAF acetylhydrolase; PAF 2-acylhydrolase; LDL-associated phospholipase A2; LDL-PLA2; lipoprotein-associated phospholipase A2; 2-acetyl-1-alkylglycerophosphocholine esterase; 1-alkyl-2-acetylglycerophosphocholine esterase (PAFAH, PLA2G7)
Function:
- modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF
- has a specificity for substrates with a short residue at the sn-2 position
- inactive against long-chain phospholipids
1-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1-alkyl-sn-glycero-3-phosphocholine + acetate
Structure:
- belongs to the AB hydrolase superfamily, lipase family
Compartment: secreted, extracellular space
Expression:
- the source of plasma PAF acetylhydrolase is not known, but cultured macrophages secrete large amounts & hepatocytes secrete less
Polymorphism:
- the alleles Thr-198 & Val-379 are associated with atopy & asthma
Pathology:
- defects in PLA2G7 are the cause of platelet-activating factor acetylhydrolase deficiency
- marker for vascular inflammation [4]
Comparative biology:
- there is apparently an intracellular enzyme of bovine brain that shares no sequence similarity outside the region of the active site
Related
lipoprotein-associated phospholipase A2 (Lp-PLA2) in serum/plasma
General
glycoprotein
phospholipase A2; phosphatidylcholine 2-acylhydrolase (PLA2)
secreted protein
Properties
SIZE: MW = 50 kD
entity length = 441 aa
COMPARTMENT: extracellular compartment
MOTIF: active site
MOTIF: serine residue {S273}
aspartate residue {D296}
histidine residue {H351}
N-glycosylation site {N423}
N-glycosylation site {N433}
Database Correlations
OMIM 601690
MORBIDMAP 601690
UniProt Q13093
Pfam PF03403
Entrez Gene 7941
Kegg hsa:7941
ENZYME 3.1.1.4.7
References
- Tjoelker LW et al
Anti-inflammatory properties of a platelet-activating factor
acetylhydrolase.
Nature 374:549 1995
PMID: 7700381
- UniProt :accession Q13093
- SeattleSNPs
http://pga.gs.washington.edu/data/pla2g7/
- Young K, Fairchild DG, Di Francesco L
FDA Clears Test to Help Predict Coronary Heart Disease Risk
Physician's First Watch, Dec 17, 2014
David G. Fairchild, MD, MPH, Editor-in-Chief
Massachusetts Medical Society
http://www.jwatch.org
- FDA News Release. December 15, 2014
FDA clears test that helps predict the risk of coronary heart
disease. Study data show test predicts risk better in black
women.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm426799.htm